ArticleScandinavian journal of trauma, resuscitation and emergency medicine2026
The role of vasopressin in trauma resuscitation: a protocol of a systematic review and meta-analysis of randomized and observational studies.
Article in Scandinavian journal of trauma, resuscitation and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHemorrhagic shock caused by trauma is one of the most important contributors to mortality in severely injured patients. Management traditionally includes hemorrhage control and aggressive fluid resuscitation. Severe hemorrhagic shock induces a state of antidiuretic hormone (vasopressin) deficiency, which exacerbates vasodilatory shock and refractory hypotension. Recent clinical trials and reviews emphasize the potential benefits of low-dose vasopressin supplementation during trauma resuscitation. Vasopressin can restore vascular tone by acting independently of the adrenergic system, improve renal perfusion, promote hemostasis, and reduce the volume of required blood product transfusions without increasing complications. In this study, we aim to review the effect of AVP in traumatic patients presenting with hemorrhagic shock.
methodsThis review is formatted according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). Quantitative randomized and observational study designs that evaluated the administration of vasopressin in trauma and hemorrhagic shock will be considered for systematic review. Databases PubMed (NCBI), PubMed Central (NCBI), Embase (Ovid), Scopus (Elsevier), and ClinicalTrials.gov (NLM) were searched for articles from 2000 to September 2025. Cochrane Library (Wiley) is also reviewed for possible systematic reviews on the subject. Further articles are sought through forward and backward citation tracking of the articles with the highest impact, especially randomized trials. Two independent blinded reviewers will screen the remaining articles for eligibility and methodological quality. Two independent authors will extract the data to decrease errors and bias. For statistical analysis, effect sizes will be expressed as risk ratios or ORs for dichotomous data or weighted (or standardized) mean differences and 95% CIs for continuous data.
trial registrationCRD420251154486. https://www.crd.york.ac.uk/PROSPERO/view/CRD420251154486.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.